Publications
Lang, F. F., C. Conrad, C. Gomez-Manzano, W. K. A. Yung, R. Sawaya, J. S. Weinberg, S. S. Prabhu, G. Rao, G. N. Fuller, K. D. Aldape, J. Gumin, L. M. Vence, I. Wistuba, J. Rodriguez-Canales, P. A. Villalobos, C. M. F. Dirven, S. Tejada, R. D. Valle, M. M. Alonso, B. Ewald, J. J. Peterkin, F. Tufaro and J. Fueyo (2018). "Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma." J Clin Oncol: JCO2017758219.
Lang, F. M., A. Hossain, J. Gumin, E. N. Momin, Y. Shimizu, D. Ledbetter, T. Shahar, S. Yamashita, B. Parker Kerrigan, J. Fueyo, R. Sawaya and F. F. Lang (2018). "Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas." Neuro Oncol 20(3): 380-390.
Figueroa, J., L. M. Phillips, T. Shahar, A. Hossain, J. Gumin, H. Kim, A. J. Bean, G. A. Calin, J. Fueyo, E. T. Walters, R. Kalluri, R. G. Verhaak and F. F. Lang (2017). "Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587." Cancer Res 77(21): 5808-5819.
Hossain, A., J. Gumin, F. Gao, J. Figueroa, N. Shinojima, T. Takezaki, W. Priebe, D. Villarreal, S. G. Kang, C. Joyce, E. Sulman, Q. Wang, F. C. Marini, M. Andreeff, H. Colman and F. F. Lang (2015). "Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway." Stem Cells 33(8): 2400-2415.
Jiang, H., K. Clise-Dwyer, K. E. Ruisaard, X. Fan, W. Tian, J. Gumin, M. L. Lamfers, A. Kleijn, F. F. Lang, W. K. Yung, L. M. Vence, C. Gomez-Manzano and J. Fueyo (2014). "Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model." PLoS One 9(5): e97407.
Shinojima, N., A. Hossain, T. Takezaki, J. Fueyo, J. Gumin, F. Gao, F. Nwajei, F. C. Marini, M. Andreeff, J. Kuratsu and F. F. Lang (2013). "TGF-beta mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells." Cancer Res 73(7): 2333-2344.
Bhat, K. P. L., V. Balasubramaniyan, B. Vaillant, R. Ezhilarasan, K. Hummelink, F. Hollingsworth, K. Wani, L. Heathcock, J. D. James, L. D. Goodman, S. Conroy, L. H. Long, N. Lelic, S. Z. Wang, J. Gumin, D. Raj, Y. Kodama, A. Raghunathan, A. Olar, K. Joshi, C. E. Pelloski, A. Heimberger, S. H. Kim, D. P. Cahill, G. Rao, W. F. A. Den Dunnen, H. W. G. M. Boddeke, H. S. Phillips, L. Nakano, F. F. Lang, H. Colman, E. P. Sulman and K. Aldape (2013). "Mesenchymal Differentiation Mediated by NF-kappa B Promotes Radiation Resistance in Glioblastoma." Cancer Cell 24(3): 331-346.
Nakamizo, A., F. Marini, T. Amano, A. Khan, M. Studeny, J. Gumin, J. Chen, S. Hentschel, G. Vecil, J. Dembinski, M. Andreeff and F. F. Lang (2005). "Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas." Cancer Res 65(8): 3307-3318.
Lang, F. F., J. M. Bruner, G. N. Fuller, K. Aldape, M. D. Prados, S. Chang, M. S. Berger, M. W. McDermott, S. M. Kunwar, L. R. Junck, W. Chandler, J. A. Zwiebel, R. S. Kaplan and W. K. A. Yung (2003). "Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological and clinical results." Journal of Clinical Oncology 21(13): 2508-2518.
View the complete list of publications from Frederick Lang, M.D.